About Virit Vichitvadakan
Virit Vichitvadakan serves on Neuvivo’s board. Neuvivo develops treatments for ALS and other neurodegenerative diseases. Since 2017, he has also served as a general partner at PrimeStreet Capital, an investment manager for venture capital and private equity.
Earlier, he worked at Saatchi & Saatchi on growth and branding for Proctor & Gamble across Southeast Asia, Australia and China.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Virit Vichitvadakan in the role, so the role may have started earlier or lasted longer.
Neuvivo, Inc. Current
Director
2023 – Present · Palo Alto, CA
Neuvivo advances NP001, an infused therapy designed to limit nerve-damaging inflammation in ALS.
PC
PrimeStreet Capital Current
General Partner
2017 – Present
SS
SAATCHI & SAATCHI
Key Colleagues at Startups
The people Virit Vichitvadakan works with at each company, as listed on that company's latest Form D.
Neuvivo, Inc. · Form D, Nov 13, 2026
MM
Michael McGrath
Chief Executive Officer and director
PP
Pornsit Poovanakijjakorn
Director
RB
Robert Baffi
Director
JC
John Curnutte
Director